United States· US:68462-659_ecbea621-93b0-40ce-adce-1d304c4fdb15
Ryaltris
A medicinal product containing olopatadine hydrochloride; mometasone furoate monohydrate, registered in United States by Glenmark Pharmaceuticals Inc., USA.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLOPATADINE HYDROCHLORIDE; MOMETASONE FUROATE MONOHYDRATE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168462-659-27
- ndc1168462-659-84
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olopatadine hydrochloride; mometasone furoate monohydrate in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaRYALTRISGLENMARK SPECIALTY SA
- PolandRyaltrisMedezin Sp. z o.o.
- NetherlandsRyaltris 25/600 microgram/dosis neusspray, suspensieMedcor Pharmaceuticals B.V.
- CzechiaRYALTRISGlenmark Pharmaceuticals s.r.o., Praha
- SwitzerlandRyaltris 25 μg / 600 μg, Nasenspray, SuspensionNOBEL Pharma Schweiz AG
- SwedenMometasone furoate/Olopatadine Glenmark 25 mikrogram/dos + 600 mikrogram/dos Nässpray, suspensionGlenmark Arzneimittel GmbH
- United KingdomRyaltris 25micrograms/dose / 600micrograms/dose nasal sprayNecessity Supplies Ltd
- IrelandRyaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspensionGlenmark Pharmaceuticals s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Ryaltris
- Belgium · Ryaltris
- Czechia · Ryaltris
- Germany · Ryaltris
- Denmark · Ryaltris
- Spain · Ryaltris
- Finland · Ryaltris
- France · Ryaltris
- United Kingdom (Northern Ireland) · Ryaltris
- Ireland · Ryaltris
- Italy · Rineffix, Ryaltris
- Lithuania · Ryaltris
- Luxembourg · Ryaltris
- Latvia · Ryaltris
- Malta · Ryaltris
- Netherlands · Ryaltris
- Norway · Ryaltris
- Poland · Ryaltris
- Romania · Ryaltris
- Sweden · Mometasone Furoate/Olopatadine Glenmark, Ryaltris
- Slovakia · Ryaltris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/22d72bbf-c9d4-4b01-bacc-80d25cfe51a8 GET /v1/drugs/22d72bbf-c9d4-4b01-bacc-80d25cfe51a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "NASAL",
"source": "ndc",
"strength": "665; 25",
"substance": "OLOPATADINE HYDROCHLORIDE; MOMETASONE FUROATE MONOHYDRATE",
"productndc": "68462-659",
"dosage_form": "SPRAY, METERED",
"dea_schedule": null,
"strength_unit": "ug/1; ug/1",
"application_number": "NDA211746",
"marketing_category": "NDA"
}See everything about olopatadine hydrochloride; mometasone furoate monohydrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.